Opioid-induced hyperalgesia (OIH)

Rev Bras Anestesiol. 2010 Nov-Dec;60(6):639-47, 355-9. doi: 10.1016/S0034-7094(10)70080-5.
[Article in English, Portuguese, Spanish]

Abstract

Background and objectives: Opioids are commonly used for pain control; however, they can cause hyperalgesia. The reason why this can happen is not known. The objective of this review was to describe the mechanisms, factors implicated, and drug modulation.

Contents: The factors implicated in the development of opioid-induced hyperalgesia (OIH), such as duration of use, dose, and type of opioids are described. Mechanisms involved include the glutamatergic system and N-methyl-D-aspartate receptors (NMDA), spinal cyclooxygenase (COX) activation, excitatory amino acids, dynorphin, cytokines and chemokines; prostaglandins, and descending facilitation. Modulation of hyperalgesia could be done through: NMDA receptor antagonists, alpha2-adrenergic agonists, and COX inhibitors.

Conclusions: This is a very complex subject, which involves a series of pathophysiological mechanisms that could contribute for OIH and patient discomfort, bringing disastrous consequences.

Publication types

  • Review

MeSH terms

  • Analgesics, Opioid / adverse effects*
  • Humans
  • Hyperalgesia / chemically induced*

Substances

  • Analgesics, Opioid